Kaabi, Nawal Al
Yang, Yun Kai
Zhang, Jing
Xu, Ke
Liang, Yu
Kang, Yun
Su, Ji Guo
Yang, Tian
Hussein, Salah
ElDein, Mohamed Saif
Shao, Shuai
Yang, Sen Sen
Lei, Wenwen
Gao, Xue Jun
Jiang, Zhiwei
Wang, Hui
Li, Meng
Mekki, Hanadi Mekki
Zaher, Walid
Mahmoud, Sally http://orcid.org/0000-0003-1348-9063
Zhang, Xue
Qu, Chang
Liu, Dan Ying
Zhang, Jing
Yang, Mengjie
Eltantawy, Islam
Xiao, Peng
Wang, Zhao Nian
Yin, Jin Liang
Mao, Xiao Yan
Zhang, Jin
Liu, Ning
Shen, Fu Jie
Qu, Liang
Zhang, Yun Tao
Yang, Xiao Ming http://orcid.org/0000-0002-2598-4355
Wu, Guizhen
Li, Qi Ming http://orcid.org/0000-0001-8284-7106
Funding for this research was provided by:
Lanzhou Institute of Biological Products Company Limited
Article History
Received: 12 January 2022
Revised: 23 March 2022
Accepted: 31 March 2022
First Online: 6 June 2022
Competing interests
: J.Z.(NVSI), Y.L., Y.K., J.G.S., S.S., S.S.Y., N.L., F.J.S. and Q.M.L. are employees of the National Vaccine and Serum Institute (NVSI). Y.K.Y., T.Y., M.L., X.Z., C.Q., D.Y.L., Z.N.W., J.L.Y., L.Q., Y.T.Z. and X.M.Y. are employees of the China National Biotec Group Company Limited. X.J.G. and X.Y.M. are employees of Lanzhou Institute of Biological Products Company Limited. H.W. and J.Z. are employees of Beijing Institute of Biological Products Company Limited. J.Z.(NVSI), Y.L., J.G.S., S.S., N.L. and Q.M.L. are listed as inventors of the patent applications for the trimeric RBD-based vaccines (Application numbers: 202110348881.6, 202110464788.1 and 202110676901.2) and a patent (Application number: 202110676901.2) has been authorized. The other authors declare no competing interests.